Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Exclusion Criteria

• •Anemia due to a cause other than CKD or presence of active bleeding or recent blood loss
• •Sickle cell disease, myelodysplastic syndromes, bone marrow fibrosis, hematologic malignancy, myeloma, hemolytic anemia, thalassemia, or pure red cell aplasia
• •Red blood cell transfusion within 4 weeks prior to or during screening
• •Intravenous iron within 4 weeks prior to or during screening
• •Any use of erythropoiesis-stimulating agents within 6 weeks prior to or during screening